2 recruiting, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Terminated 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow HLH: new trials by email Literature Review of HLH trials Research Report on HLH
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT Phase 1 Dose Level 1, Phase 1 Dose Level 2, Phase 1 Dose Level 3 - Leukemia, High Risk Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Recruiting | Children's Hospital of Philadelphia | 100 | 2025-03-21 | 2026-04-15 |
| Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis 68GaNOTA-Anti-MMR-VHH2 - Solid Malignancy Located in the Head and Neck, Cancer | Phase 2 | Terminated | Universitair Ziekenhuis Brussel | 29 | 2021-01-26 | 2026-06-01 |
| Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders Clofarabine, Fludarabine, Busulfan - AML, ALL | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 31 | 2020-11-20 | 2026-03-13 |
Lymphoma, Non-Hodgkin (3) · Anemia, Refractory, with Excess of Blasts (2) · Bone Marrow Failure Disorders (2) · Hemoglobinopathies (2) · Carotid Stenosis (1) · Congenital Bone Marrow Failure Syndromes (1) · Hodgkin Disease (1) · Immunologic Deficiency Syndromes (1) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Metabolism, Inborn Errors (1) · Myeloproliferative Disorders (1) · Neoplasms (1) · Sarcoidosis (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma (3) · Lymphoproliferative Disorders (3) · Neoplasms by Histologic Type (3) · Anemia (2) · Anemia, Refractory (2) · Bone Marrow Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hematologic Diseases (2) · Myelodysplastic Syndromes (2) · Neoplasms (2)
Busulfan (1) · Clinical Trials, Phase I as Topic (1) · Clofarabine (1) · Cyclosporins (1) · Mycophenolic Acid (1) · fludarabine (1) · fludarabine phosphate (1)
Children's Hospital of Philadelphia (1) · Memorial Sloan Kettering Cancer Center (1) · Universitair Ziekenhuis Brussel (1)
United States (2) · Belgium (1)
Maria Cancio, MD (1) · Timothy Olson, MD, PhD (1) · Tony Lahoutte, MD (1)